Resistin levels in women with ischemic stroke

Neuroendocrinology Letters

Volumn 33, Issue 6, 2012, Pages 603-607

  Kochanowski, Jan ^a   Grudniak, Mariusz ^a   Baranowska Bik, Agnieszka ^b   Wolinska Witort, Ewa ^b   Kalisz, Malgorzata ^b   Baranowska, Boguslawa ^b   Bik, Wojciech ^b  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

Author keywords

Adipose tissue; Ischemic stroke; Resistin; Tumor necrosis factor alpha

Indexed keywords

EID: 84871072932     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Barone FC, Arvin B, White RF, Miller A, Webb CL, Willette RN, et al (1997). Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury. Stroke. 28: 1233-1244. (Pubitemid 27248902)
2. Burnett MS, Lee CW, Kinnaird TD, Stabile E, Durrani S, Dullum MK, et al (2005). The potential role of resistin in atherogenesis. Atherosclerosis. 182: 241-248. (Pubitemid 41267191)
3. Calabro P, Samudio I, Willerson JT, Yeh ET (2004). Resistin promotes smooth muscle cell proliferation through activation of extracellular signal-regulated kinase 1/2 and phosphatidylinositol 3-kinase pathways. Circulation. 110: 3335-3340. (Pubitemid 39557496)
4. Cho Y, Lee SE, Lee HC, Hur J, Lee S, Youn SW, et al (2011) . Adipokine resistin is a key player to modulate monocytes, endothelial cells, and smooth muscle cells, leading to progression of atherosclerosis in rabbit carotid artery. J Am Coll Cardiol. 57: 99-109.
5. DeGraba TJ (1998). The role of inflammation after acute stroke: utility of pursuing anti-adhesion molecule therapy. Neurology 51: 62-68.
6. Efstathiou SP, Tsiakou AG, Tsioulos DI, Panagiotou TN, Pefanis AV, Achimastos AD, et al (2007). Prognostic significance of plasma resistin levels in patients with atherothrombotic ischemic stroke. Clin Chim Acta. 378: 78-85.
7. Galic S, Oakhill JS, Steinberg GR (2010). Adipose tissue as an endocrine organ. Mol Cell Endocrinol. 316: 129-139.
8. Hallenbeck JM (2002). The many faces of tumor necrosis factor in stroke. Nat Med. 8: 1363-1368.
9. Karbowska A, Boratynska M, Klinger M (2009). Rezystyna - czynnik patogenetyczny czy biomarker zaburzeń metabolicznych i zapalenia? [Resistin: a pathogenic factor or a biomarker of metabolic disorders and inflammation? (In Polish with English abstract)]. Postepy Hig Med Dosw. 63: 485-491.
10. Kershaw EE, Flier JS (2004). Adipose tissue as an endocrine organ. J Clin Endocrinol Metab. 89: 2548-2556. (Pubitemid 38766330)
11. Kuklina EV, Tong X, George MG, Bansil P (2012). Epidemiology and prevention of stroke: a worldwide perspective. Expert Rev Neurother. 12: 199-208.
12. Lyden P, Brott T, Tilley B, Welch KM, Mascha EJ, Levine S, et al (1994). Improved reliability of the NIH Stroke Scale using video training. NINDS TPA Stroke Study Group. Stroke. 25: 2220-2226. (Pubitemid 24338379)
13. Mazzotta G, Sarchielli P, Caso V, Paciaroni M, Floridi A, Gallai V (2004). Different cytokine levels in thrombolysis patients as predictors for clinical outcome. Eur J Neurol. 11: 377-381. (Pubitemid 39272941)
14. Mortality Data. Geneva, World Health Organization (2011).
15. Nagaev I, Smith U (2001). Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle. Biochem Biophys Res Commun. 285: 561-564. (Pubitemid 32918109)
16. Prugger C, Luc G, Haas B, Arveiler D, Machez E, Ferrieres J, et al (2012). Adipocytokines and the risk of ischemic stroke: the PRIME Study. Ann Neurol. 71: 478-486.
17. Rajpathak SN, Kaplan RC, Wassertheil-Smoller S, Cushman M, Rohan TE, McGinn AP, et al (2011). Resistin, but not adiponectin and leptin, is associated with the risk of ischemic stroke among postmenopausal women: results from the Women's Health Initiative. Stroke. 42: 1813-1820.
18. Reilly MP, Lehrke M, Wolfe ML, Rohatgi A, Lazar MA, Rader DJ (2005). Resistin is an inflammatory marker of atherosclerosis in humans. Circulation. 111: 932-939. (Pubitemid 40279897)
19. Sacco RL (1995). Risk factors and outcomes for ischemic stroke. Neurology. 45: 10-14.
20. Sieber MW, Claus RA, Witte OW, Frahm C (2011). Attenuated inflammatory response in aged mice brains following stroke. PLoS One. 6: e26288.
21. Sommer G, Kralisch S, Stangl V, Vietzke A, Kohler U, Stepan H, et al (2009). Secretory products from human adipocytes stimulate proinflammatory cytokine secretion from human endothelial cells. J Cell Biochem. 106: 729-737.
22. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, et al (2001): The hormone resistin links obesity to diabetes. Nature. 409: 307-312. (Pubitemid 32151228)
23. Steppan CM, Lazar MA (2004). The current biology of resistin. J Intern Med. 255: 439-447. (Pubitemid 38446357)
24. Tuttolomondo A, Di Raimondo D, Pecoraro R, Arnao V, Pinto A, Licata G (2012). Inflammation in Ischemic Stroke Subtypes. Curr Pharm Des. [Epub ahead of print]
25. Weikert C, Westphal S, Berger K, Dierkes J, Mohlig M, Spranger J, et al (2008). Plasma resistin levels and risk of myocardial infarction and ischemic stroke. J Clin Endocrinol Metab. 93: 2647-2653. (Pubitemid 352008532)
26. You T, Nicklas BJ (2006). Chronic inflammation: role of adipose tissue and modulation by weight loss. Curr Diabetes Rev. 2: 29-37. (Pubitemid 44082948)
27. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM (1994). Positional cloning of the mouse obese gene and its human homologue. Nature. 372: 425-432. (Pubitemid 24365442)